Skip to main content
. 2022 Jul 11;19(8):1241–1253. doi: 10.7150/ijms.70706

Figure 6.

Figure 6

Therapeutic response of PDX (Case702) to MDM2 inhibitor RG7112. (a-b) Compared with control group, the tumor volume of mice in treatment group were significantly reduced.*:PDX tumors. (c) The mice treated with RG7112 had a lower PDX growth rate (p=0.015).